Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study
预测乐伐替尼治疗不可切除肝细胞癌患者生存获益的药效学生物标志物:来自 III 期 REFLECT 研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-4219
Finn, Richard S; Kudo, Masatoshi; Cheng, Ann-Lii; Wyrwicz, Lucjan; Ngan, Roger K C; Blanc, Jean-Frederic; Baron, Ari D; Vogel, Arndt; Ikeda, Masafumi; Piscaglia, Fabio; Han, Kwang-Hyub; Qin, Shukui; Minoshima, Yukinori; Kanekiyo, Michio; Ren, Min; Dairiki, Ryo; Tamai, Toshiyuki; Dutcus, Corina E; Ikezawa, Hiroki; Funahashi, Yasuhiro; Evans, Thomas R Jeffry